Wildon Farwell Dyne Therapeutics, Inc. (DYN) insider trading activity

Wildon Farwell is Chief Medical Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 143,222 shares of DYN, which is worth approximately $3.44 Million. The most recent transaction as insider was on Aug 19, 2024, when has been sold 2,321 shares (Common Stock) at a price of $45.5 per share, resulting in proceeds of $105,605. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 143K

0% 3M change

15.3% 12M change

Total Value Held $3.44 Million

Wildon Farwell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 19 2024	SELL Open market or private sale	$105,605 $45.5 p/Share	2,321 Reduced 1.59%	143,222 Common Stock
Jun 11 2024	SELL Open market or private sale	$82,427 $31.27 p/Share	2,636 Reduced 1.78%	145,543 Common Stock
May 16 2024	SELL Open market or private sale	$67,620 $28.4 p/Share	2,381 Reduced 1.58%	148,179 Common Stock
Mar 12 2024	SELL Open market or private sale	$26,347 $25.58 p/Share	1,030 Reduced 0.68%	150,560 Common Stock
Mar 11 2024	SELL Open market or private sale	$40,734 $25.7 p/Share	1,585 Reduced 1.03%	151,590 Common Stock
Mar 07 2024	SELL Open market or private sale	$257,946 $26.0 p/Share	9,921 Reduced 6.08%	153,175 Common Stock
Feb 28 2024	SELL Open market or private sale	$10,175 $25.0 p/Share	407 Reduced 0.25%	163,096 Common Stock
Feb 12 2024	SELL Open market or private sale	$137,709 $25.07 p/Share	5,493 Reduced 3.25%	163,503 Common Stock
Jan 26 2024	SELL Open market or private sale	$2,500 $25.0 p/Share	100 Reduced 0.06%	168,996 Common Stock
Dec 12 2023	SELL Open market or private sale	$10,317 $10.55 p/Share	978 Reduced 0.58%	169,096 Common Stock
Dec 11 2023	SELL Open market or private sale	$18,095 $10.72 p/Share	1,688 Reduced 0.98%	170,074 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	-	82,512 Added 32.45%	171,762 Common Stock
Sep 12 2023	SELL Open market or private sale	$17,769 $10.41 p/Share	1,707 Reduced 1.88%	89,250 Common Stock
Jun 13 2023	SELL Open market or private sale	$21,106 $12.43 p/Share	1,698 Reduced 1.83%	90,957 Common Stock
Mar 14 2023	SELL Open market or private sale	$99,188 $13.33 p/Share	7,441 Reduced 7.43%	92,655 Common Stock
Dec 12 2022	SELL Open market or private sale	$6,826 $10.87 p/Share	628 Reduced 0.62%	100,096 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	36,000 Added 26.33%	100,724 Common Stock
Sep 15 2022	SELL Sale (or disposition) back to the issuer	$9,245 $14.05 p/Share	658 Reduced 1.01%	64,724 Common Stock
Jun 14 2022	SELL Sale (or disposition) back to the issuer	$3,307 $4.95 p/Share	668 Reduced 1.01%	65,382 Common Stock
Mar 11 2022	SELL Open market or private sale	$5,587 $8.73 p/Share	640 Reduced 0.96%	66,050 Common Stock
Mar 02 2022	SELL Open market or private sale	$48,082 $8.56 p/Share	5,617 Reduced 7.77%	66,690 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	-	22,307 Added 23.58%	72,307 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	50,000 Added 50.0%	50,000 Common Stock

Wildon Farwell

Chief Medical Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Value

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dyne Therapeutics, Inc.

Track Activities on DYN

Account